These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 32352102

  • 1. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
    Qu J, Teng D, Sui G, Guan S, Wang Y, Wang Q, Lin Y, Ran H, Wang Z, Wang H.
    Biomater Sci; 2020 Jun 07; 8(11):3116-3129. PubMed ID: 32352102
    [Abstract] [Full Text] [Related]

  • 2. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y, Xie Y, Li J, Peng ZH, Sheinin Y, Zhou J, Oupický D.
    ACS Nano; 2017 Feb 28; 11(2):2227-2238. PubMed ID: 28165223
    [Abstract] [Full Text] [Related]

  • 3. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy.
    Zhang G, Wang W, Zou H, Wei Z, Song C, Ran J, Cao Z, Cai Y, Han W.
    J Mater Chem B; 2021 Jul 07; 9(26):5318-5328. PubMed ID: 34231629
    [Abstract] [Full Text] [Related]

  • 4. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
    Wang H, Zhang C, Zhang Y, Tian R, Cheng G, Pan H, Cui M, Chang J.
    J Mater Chem B; 2020 Apr 08; 8(14):2876-2886. PubMed ID: 32191252
    [Abstract] [Full Text] [Related]

  • 5. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.
    Ma B, Sheng J, Wang P, Jiang Z, Borrathybay E.
    Int J Nanomedicine; 2019 Apr 08; 14():4541-4558. PubMed ID: 31417257
    [Abstract] [Full Text] [Related]

  • 6. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
    Dong Y, Zhou L, Shen Z, Ma Q, Zhao Y, Sun Y, Cao J.
    Drug Deliv; 2022 Dec 08; 29(1):238-253. PubMed ID: 35001784
    [Abstract] [Full Text] [Related]

  • 7. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
    Song C, Xu W, Wei Z, Ou C, Wu J, Tong J, Cai Y, Dong X, Han W.
    J Mater Chem B; 2020 Jan 28; 8(4):648-654. PubMed ID: 31898718
    [Abstract] [Full Text] [Related]

  • 8. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
    Liu H, Jiang W, Wang Q, Hang L, Wang Y, Wang Y.
    Biomater Sci; 2019 Aug 20; 7(9):3706-3716. PubMed ID: 31187794
    [Abstract] [Full Text] [Related]

  • 9. A triple-stimulus responsive melanin-based nanoplatform with an aggregation-induced emission-active photosensitiser for imaging-guided targeted synergistic phototherapy/hypoxia-activated chemotherapy.
    Yu J, Zhang X, Pei Z, Shuai Q.
    J Mater Chem B; 2021 Nov 17; 9(44):9142-9152. PubMed ID: 34693960
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.
    Huang X, Wu J, He M, Hou X, Wang Y, Cai X, Xin H, Gao F, Chen Y.
    Mol Pharm; 2019 May 06; 16(5):2172-2183. PubMed ID: 30978027
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hyaluronan-fullerene/AIEgen nanogel as CD44-targeted delivery of tirapazamine for synergistic photodynamic-hypoxia activated therapy.
    Hong X, Xu X, Liu Z, Liu S, Yu J, Wu M, Ma Y, Shuai Q.
    Nanotechnology; 2021 Aug 23; 32(46):. PubMed ID: 34325415
    [Abstract] [Full Text] [Related]

  • 14. Optimized Combination of Photodynamic Therapy and Chemotherapy Using Gelatin Nanoparticles Containing Tirapazamine and Pheophorbide a.
    Lee D, Jang SY, Kwon S, Lee Y, Park E, Koo H.
    ACS Appl Mater Interfaces; 2021 Mar 10; 13(9):10812-10821. PubMed ID: 33624503
    [Abstract] [Full Text] [Related]

  • 15. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
    Dai Y, Wang B, Sun Z, Cheng J, Zhao H, Wu K, Sun P, Shen Q, Li M, Fan Q.
    ACS Appl Mater Interfaces; 2019 Oct 30; 11(43):39410-39423. PubMed ID: 31578854
    [Abstract] [Full Text] [Related]

  • 16. Photodynamic Therapy with Liposomal Zinc Phthalocyanine and Tirapazamine Increases Tumor Cell Death via DNA Damage.
    Broekgaarden M, Weijer R, van Wijk AC, Cox RC, Egmond MR, Hoebe R, van Gulik TM, Heger M.
    J Biomed Nanotechnol; 2017 Feb 30; 13(2):204-20. PubMed ID: 29377650
    [Abstract] [Full Text] [Related]

  • 17. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z, Chen Y, Zhang J, Li W, Shi M, Qiao M, Zhao X, Hu H, Chen D.
    ACS Appl Mater Interfaces; 2021 Aug 25; 13(33):39934-39948. PubMed ID: 34396771
    [Abstract] [Full Text] [Related]

  • 18. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
    Li L, Fu J, Ye J, Liu L, Sun Z, Wang H, Tan S, Zhen M, Wang C, Bai C.
    Adv Mater; 2024 Jun 25; 36(23):e2310875. PubMed ID: 38450765
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.